HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ruey-Hwang Chou Selected Research
Ruey-Hwang Chou Research Topics
Disease
32
Neoplasms (Cancer)
01/2021 - 01/2002
6
Breast Neoplasms (Breast Cancer)
01/2021 - 04/2009
5
Neoplasm Metastasis (Metastasis)
01/2021 - 04/2009
4
Hepatocellular Carcinoma (Hepatoma)
10/2018 - 01/2012
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 12/2006
2
Brain Neoplasms (Brain Tumor)
04/2022 - 03/2013
2
Hearing Loss (Hearing Impairment)
01/2022 - 06/2021
2
Inflammation (Inflammations)
01/2022 - 11/2016
2
Infections
10/2018 - 01/2012
2
Uterine Cervical Neoplasms (Cancer of the Cervix)
07/2017 - 01/2013
2
Triple Negative Breast Neoplasms
09/2014 - 01/2013
2
Chronic Hepatitis B
01/2014 - 01/2012
2
Wounds and Injuries (Trauma)
01/2014 - 04/2009
2
Adenocarcinoma of Lung
06/2011 - 04/2009
2
Carcinoma (Carcinomatosis)
04/2009 - 04/2002
1
Ototoxicity
01/2022
1
Periodontitis
07/2020
1
Macular Degeneration (Age-Related Maculopathy)
10/2018
1
Postoperative Hemorrhage
07/2018
1
Pain (Aches)
07/2018
1
Carcinogenesis
11/2016
1
Aphthous Stomatitis (Aphthous Ulcer)
01/2016
1
Ataxia Telangiectasia (Louis Bar Syndrome)
06/2015
1
Lymphoma (Lymphomas)
09/2014
1
Stroke (Strokes)
04/2013
1
Glioblastoma (Glioblastoma Multiforme)
03/2013
Drug/Important Bio-Agent (IBA)
12
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2002
4
Peptides (Polypeptides)
IBA
01/2020 - 01/2012
3
Pharmaceutical Preparations
IBA
11/2020 - 09/2014
2
Cisplatin (Platino)
FDA Link
Generic
01/2022 - 06/2021
2
Suramin (Suramin Sodium)
IBA
01/2021 - 11/2020
2
ErbB Receptors (EGF Receptor)
IBA
01/2021 - 07/2014
2
MicroRNAs (MicroRNA)
IBA
07/2020 - 05/2017
2
Biological Products
IBA
08/2018 - 12/2006
2
Matrix Metalloproteinases (MMPs)
IBA
07/2017 - 10/2015
2
Antioxidants
IBA
07/2017 - 12/2010
2
Histones (Histone)
IBA
05/2017 - 07/2014
2
Tubulin
IBA
01/2016 - 06/2015
2
DNA-Activated Protein Kinase
IBA
06/2015 - 09/2012
2
Messenger RNA (mRNA)
IBA
01/2014 - 09/2012
2
Polysaccharides (Glycans)
IBA
01/2014 - 01/2012
2
1-phenyl-3,3-dimethyltriazene (PDT)
IBA
01/2013 - 04/2009
2
Kallikreins (Kallikrein)
IBA
06/2011 - 12/2006
1
Air Pollutants (Pollutants, Air)
IBA
04/2022
1
RNA (Ribonucleic Acid)
IBA
06/2021
1
Tyrosine Kinase Inhibitors
IBA
01/2021
1
Glucose (Dextrose)
FDA Link
Generic
01/2021
1
Pentamidine (NebuPent)
FDA Link
Generic
01/2021
1
Enhancer of Zeste Homolog 2 Protein
IBA
07/2020
1
Chemokine Receptors
IBA
07/2020
1
S100 Calcium-Binding Protein A4
IBA
01/2020
1
Calcium-Binding Proteins
IBA
01/2020
1
Retinal Pigments (Pigments, Visual)
IBA
10/2018
1
BAY 11-7085
IBA
01/2018
1
Caspase 3 (Caspase-3)
IBA
07/2017
1
Reactive Oxygen Species (Oxygen Radicals)
IBA
07/2017
1
mangostin
IBA
07/2017
1
Cytochromes c (Cytochrome c)
IBA
07/2017
1
Caspase 9
IBA
07/2017
1
Calcium
IBA
11/2016
1
Anti-Allergic Agents (Antiallergic Agents)
IBA
01/2016
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2016
1
amlexanox (Aphthasol)
FDA Link
01/2016
1
Membrane Proteins (Integral Membrane Proteins)
IBA
10/2015
1
Checkpoint Kinase 2
IBA
06/2015
1
CSC-3436
IBA
06/2015
1
Checkpoint Kinase 1
IBA
06/2015
1
Phosphotransferases (Kinase)
IBA
06/2015
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
09/2014
1
Fucosyltransferases
IBA
04/2014
1
Globo-H
IBA
04/2014
1
Antigens
IBA
04/2014
1
Carbohydrates
IBA
04/2014
1
Oligosaccharides
IBA
01/2014
1
Advanced Glycation End Products
IBA
01/2014
1
Cell Surface Receptors
IBA
01/2014
1
Fetal Proteins (Fetoprotein)
IBA
01/2014
1
Rosiglitazone (Avandia)
FDA Link
04/2013
1
Immunoglobulins (Immunoglobulin)
IBA
03/2013
1
Plasminogen Activators (Plasminogen Activator)
IBA
01/2013
1
Flavonoids
IBA
01/2013
1
fisetin
IBA
01/2013
1
SB 203580
IBA
01/2013
1
p38 Mitogen-Activated Protein Kinases
IBA
01/2013
1
Tyrosine (L-Tyrosine)
FDA Link
01/2013
1
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
01/2013
1
4- carboxy- 5- (pyridyloxy- 5'- phosphate)proline
IBA
01/2013
1
Nuclear Antigens (Extractable Nuclear Antigens)
IBA
01/2013
1
Proliferating Cell Nuclear Antigen (PCNA)
IBA
01/2013
1
Chlorides
IBA
01/2013
Therapy/Procedure
6
Therapeutics
01/2021 - 06/2015
2
Radiotherapy
03/2013 - 09/2012
1
Intravenous Administration
01/2022
1
Oral Hygiene (Dental Hygiene)
07/2020
1
Operative Time
07/2018
1
Length of Stay
07/2018
1
Transplantation
01/2014
1
Immunotherapy
03/2013
1
Drug Therapy (Chemotherapy)
03/2013
1
Photochemotherapy (Photodynamic Therapy)
01/2013